相似文献
1
Vaccine against SARS-CoV-2 in previously infected health care workers.
EBioMedicine. 2021 Sep;71:103556. doi: 10.1016/j.ebiom.2021.103556. Epub 2021 Aug 26.
2
Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
EBioMedicine. 2021 Sep;71:103567. doi: 10.1016/j.ebiom.2021.103567. Epub 2021 Aug 26.
3
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
PLoS Med. 2021 Sep 13;18(9):e1003772. doi: 10.1371/journal.pmed.1003772. eCollection 2021 Sep.
4
Being fair to participants in placebo-controlled COVID-19 vaccine trials.
Nat Med. 2021 Jun;27(6):938. doi: 10.1038/s41591-021-01338-1.
5
Messenger RNA vaccines against SARS-CoV-2.
Cell. 2021 Mar 18;184(6):1401. doi: 10.1016/j.cell.2020.12.039. Epub 2021 Jan 13.
6
Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Protein Cell. 2021 Oct;12(10):818-823. doi: 10.1007/s13238-021-00840-z. Epub 2021 Apr 28.
7
COVID-19 vaccines for patients with haematological conditions.
Lancet Haematol. 2021 May;8(5):e312-e314. doi: 10.1016/S2352-3026(21)00073-9. Epub 2021 Mar 31.
8
How nano can fight the virus.
Nat Mater. 2021 Feb;20(2):126. doi: 10.1038/s41563-020-00916-x.
9
[Vaccination immunology in SARS-CoV-2].
Ugeskr Laeger. 2021 Mar 15;183(11).
10
COVID vaccines slash viral spread - but Delta is an unknown.
Nature. 2021 Aug;596(7870):17-18. doi: 10.1038/d41586-021-02054-z.
Zotero 插件